BTG

WIPO WIPO 2016

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark BTG was filed as Figurative mark on 03/31/2016 at the World Intellectual Property Organization.

Logodesign (Wiener Klassifikation)

#Circles #Lines, bands #Circles containing other figurative elements #Circles with dark surfaces or parts of surfaces #Oblique lines or bands

Trademark Details Last update: January 10, 2023

Trademark form Figurative mark
File reference 1308581
Countries Australia Switzerland China Colombia European Community Israel India Iceland Japan South Korea Norway New Zealand Philippines Serbia Russia Singapore San Marino Turkey Vietnam
Base trademark GB No. UK00003157313, March 31, 2016
Application date March 31, 2016
Expiration date March 31, 2026

Trademark owner

100 New Bridge Street
London EC4V 6JA
GB

Trademark representatives

Seventh Floor Offices Artillery House GB

goods and services

05 Pharmaceutical and medicinal preparations and substances; veterinary preparations and substances; sanitary preparations for medical purposes; dietetic substances adapted for medical use, vaccines; sera; diagnostic reagents and substances, all for in vivo use; antibodies, therapeutic antibodies for use as anti-lymphocytic agents; pharmaceutical preparations in the form of foams or for use in producing foams; pharmaceutical preparations in the form of foams or for use in producing foams, for sclerotherapy, phlebology, angiology or proctology, for treatment of oesophageal varices, hydroceles, in sterilisation treatment or for treatment of varicose veins, or arterio-venous malformations; chemical reagents for medical or veterinary purposes; chemical reagents for therapeutic and diagnostic purposes; chemico-pharmaceutical preparations; chemical preparations for medical or pharmaceutical purposes; pharmaceutical preparations for the treatment of cancer; pharmaceutical and veterinary preparations for the reduction or elimination of circulating cytokines; pharmaceutical and veterinary preparations for the treatment of digoxin, digitalis or other cardio-active glycoside toxicity; pharmaceutical and veterinary preparations for treatment of envenomation by snakes; pharmaceutical and veterinary preparations for the treatment of hypertension; pharmaceutical preparations for the treatment of migraine; pharmaceutical preparations for the treatment of multiple neurodegeneration and multiple sclerosis; pharmaceutical preparations for the treatment of Alzheimer's disease; pharmaceutical preparations for the treatment of methotrexate toxicity; pharmaceutical preparations for the treatment of immune disorders including type 1 diabetes, psoriasis, coeliac disease and rheumatoid arthritis; pharmaceutical preparations for the treatment of cancer including prostate, oesophageal and brain cancer and leukaemias; pharmaceutical preparations for the treatment of sepsis; preparations and substances for facilitating the delivery of pharmaceutical and medicinal preparations and substances; pharmaceutical preparations and substances for use in the circulatory system; pharmaceutical preparations and substances for embolization; pharmaceutical preparations and substances for embolization of tumours and arteriovenous malformations (AVMs); pharmaceutical prepraations and substances for use in the circulatory system for the treatment of tumours and arteriovenous malformations (AVMs); adjuvants for medicinal purposes, vaccine adjuvants and vaccine preparations containing adjuvant; chemical reagents for medical or veterinary purposes for the treatment of envenomation by snakes; chemical reagents for therapeutic and diagnostic purposes for the treatment of envenomation by snakes; chemical preparations for medical or pharmaceutical purposes for the treatment of envenomation by snakes; medicines for the treatment of envenomation by snakes; pharmaceutical and veterinary preparations for the treatment of pre-eclampsia; chemical reagents for medical or veterinary therapeutic and diagnostic purposes; chemico-pharmaceutical preparations for use in the treatment of digoxin, digitalis or other cardio-active glycoside toxicity, and for use in the treatment of pre-eclampsia; chemical preparations for medical or pharmaceutical purposes and medicines for use in the treatment of digoxin, digitalis or other cardio-active glycoside toxicity and for use in the treatment of pre-eclampsia; transarterial chemoembolization pharmaceutical preparations, vaccines and sera; pharmaceutical preparations and substances for facilitating the delivery of pharmaceutical and medicinal preparations and substances; irradiated or radioactive microspheres used for in vivo therapeutic medical purposes; radiotherapy substances for medical purposes; radiopharmaceuticals; therapeutic agents for delivery of radioactive material to target sites within the body; beads, including microscopic radioactive beads, for treatment of cancerous tumours; beads, including microscopic glass beads, impregnated with radioactive material for treatment of cancerous tumours; beads, radioactive glass beads for medical purposes; pharmaceutical preparations for use with ultrasound waves to enhance drug delivery and/or medically activate drugs; pharmaceutical preparations in the form of foams for use in sclerotherapy treatment of veins; pharmaceutical preparations in the form of foams for use in producing foams for use in sclerotherapy treatment of veins; pharmaceutical preparations in the form of foams or for use in producing foams for sclerotherapy, phlebology, angiology and proctology, for treatment of oesophageal varices, hydroceles, in sterilisation treatment or for treatment of varicose veins, or arterio-venous malformations; pharmaceutical preparations containing methotrexate antidotes; pharmaceutical preparations containing 5-fluorouracil antidotes; pharmaceutical preparations for use in chemotherapy and autoimmune diseases; pharmaceutical preparations used for regulating toxicity levels of therapeutic agents; pharmaceutical preparations used for depleting concentrations of therapeutic agents
09 Scientific, measuring, checking (supervision), teaching apparatus and instruments; magnetic data carriers, data carriers, databases, recording discs; data in machine-readable form; electronically, optically or magnetically recorded data; recorded films, tapes, compact discs, laser discs, CD-ROM's, DVDs and other digital recording media and cassettes bearing sound and/or images; data processing equipment, computers; apparatus and instruments for receiving, collecting, capturing, acquiring, collating, recording, transmitting, storing, analysing, processing, developing, converting, accessing, handling, displaying, encoding, logging, relaying, communicating, inputting, outputting and/or reproducing data, sound and/or images; computer installations, apparatus and instruments; computer imaging systems; imaging apparatus; apparatus, peripheral apparatus, components and instruments for use with computers; computer firmware; computer hardware; computer peripherals; computer software and computer programmes; computer software for use in medical devices; computer software for use in ultrasound devices; computer software for use in the medical and/or pharmaceutical fields; computer software and computer programmes providing information to medical professionals and patients; computer software and telecommunications apparatus (including modems) to enable connection to databases and the internet; computer software to enable searching for data; computer programs for use in the field of health care for the collection, maintenance and management of data for patient records, clinical diagnosis and assessment, patient treatment, goals management, outcome analysis, scheduling, health care facilities management, materials management, resources utilization, billing and accounting, and the review of health care facilities, services and clinical records; computer software for use by health care providers to analyse the outcomes of medical procedures and information relating to patient care; computer software for use in database management; computer databases for clinical use, clinical governance, clinical audit, collecting and analysing information relating to patient demographics, procedures and outcomes; computer software and computer displays for use in relation to medical purposes; computer hardware, computer software and computer programs in the field of ultrasound technology; apparatus for generating and transmitting ultrasound; electric and electronic control systems for controlling medical apparatus and instruments; electric and electronic control systems for controlling apparatus for generating and transmitting ultrasound; data processing apparatus and computers for controlling medical apparatus and instruments; data processing apparatus and computers for controlling apparatus for generating and transmitting ultrasound; computer software for controlling medical apparatus and instruments; computer software for controlling apparatus for generating and transmitting ultrasound; stands for computer equipment; medical software for processing and displaying images on ultrasound medical imaging apparatus; medical imaging software that records, monitors and analyses data using an ultrasound imaging probe; medical workstation comprised of computer hardware and software for gathering and transmitting patient image data for use during surgical procedures; software for processing digital images of the anatomy for diagnosis and treatment; software for medical imaging; equipment for scientific research and for diagnosis, including ultrasound imaging systems comprising ultrasound scanners, ultrasound imaging devices, and ancillary equipment; computer software for use in relation to ultrasound imaging and scanning; imaging units; electronic apparatus and instruments for use in relation to ultrasound imaging and scanning; downloadable electronic questionnaires; downloadable electronic patient reported outcome questionnaires; downloadable electronic patient reported outcome questionnaires for use with a telecommunications device; downloadable publications in electronic form; downloadable electronic publications provided on-line from databases or the internet; computer software and downloadable publications in electronic form supplied on-line from databases or from facilities provided on the internet (including websites); optical detection, inspection, measuring and testing apparatus and instruments; optical viewing and recording apparatus; electrically operated diagnostic testing apparatus and instruments; spectrophotometers; ultrasonic diagnostic apparatus; parts and fittings for all the aforesaid goods
10 Surgical, medical, dental and veterinary apparatus and instruments; artificial limbs, orthopaedic articles; syringes, cannula needles, medical tubing; surgical and medical apparatus for producing and administering foams; surgical and medical apparatus for producing and administering sclerosing foams; surgical or medical apparatus for or for producing foams for use in sclerotherapy, phlebology, angiology or proctology, sterilisation treatment or for treatment of varicose veins, arterio-venous malformations, oesophageal varices or hydroceles; surgical and medical devices for assessing the physical characteristics of such foams, devices for intravenous administration of foam and devices for monitoring the position and effect of foam in the human body; diagnostic devices for use in all the above medical conditions; haemofiltration devices; drug delivery embolisation apparatus, instruments and systems; apparatus and instruments for use in the circulatory system; apparatus and instruments for embolisation; surgical and medical apparatus and instruments, namely, catheters, injection syringes and sealed vial devices for dispensing microspheres during embolisation procedures in blood vessels and in the circulatory system; embolisation apparatus, instruments and systems comprising surgical and medical instruments for embolisation; drug delivery embolisation systems; drug delivery apparatus and instruments comprised of injection syringes, and sealed vials; injection syringes for use with catheters; apparatus and instruments for use in the circulatory system, namely, catheters, injection syringes and sealed vials; medical apparatus and instruments for embolisation; surgical and medical apparatus and instruments for embolisation, namely, embolisation apparatus, instruments and systems comprising microspheres and injection syringes for use in blood vessels and the circulatory system to carry out embolisation; radiotherapy apparatus; surgical and medical apparatus and instruments for delivery of radiopharmaceuticals and radioactive material to target sites within the body; beads, including microscopic glass beads, impregnated with radioactive material or containing radioactive material and administered surgically for treatment of cancerous tumours; radioactive beads, including radioactive glass beads administered for treatment of cancerous tumours; surgical and medical apparatus and instruments for use in the circulatory system; medical devices which use ultrasound to enhance drug delivery and/or medically activate drugs; catheters for delivery of drugs or fluids and controllers and power units for infusion catheters; ultrasonic drug delivery and drug activation apparatus and controllers and power units therefor; needles for medical use, namely, cannula needles; medical tubing for sclerotherapy; medical tubing for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; surgical and medical apparatus for producing and administering foams for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; surgical and medical apparatus for producing and administering sclerosing foams for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; syringes for producing and administering foams for use in sclerotherapy, phlebology, angiology or proctology; surgical and medical apparatus for administering and producing foams for use in sterilisation treatment; surgical and medical apparatus for use in treatment of varicose veins, arterio-venous malformations, oesophageal varices or hycroceles; syringes for use in treatment of varicose veins, arterio-venous malformations, oesophageal varices or hydroceles; surgical and medical devices for assessing the physical characteristics of such foams; medical devices for intravenous administration of sclerosing foam for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; medical devices for monitoring the position and effect of foam in the human body; medical diagnostic apparatus for diagnosing all the above medical conditions; compression bandages; surgical, medical and diagnostic materials, devices, apparatus and instruments for use in interventional pulmonology; medical devices for use in pulmonary and thoracic surgery and procedures; lung volume reduction devices; artificial surgical implants for use in interventional pulmonology; surgical implants comprising artificial surgical implants for restoring, maintaining and improving patient breathing, and artificial surgical implants for restoring, maintaining and improving lung function; parts and fittings for all of the aforesaid goods
41 Education; provision of educational content; provision of educational content for apps (applications) for mobile devices and computers; providing education information in the fields of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine and patient care by means of computer, electronic and online databases; provision of education and training in the fields of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine and patient care; provision of education and training in the field of health and medical information and related hotline services; arranging, and conducting educational conferences and programs and providing courses of instruction in the fields of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine and patient care; provision and publication of educational material and content in the fields of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine and patient care; conducting educational seminars in the fields healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine and patient care and distribution of course materials therewith; information and advice relating to education, training and development provided online from a computer database or the internet, all relating to healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine and patient care; providing teaching guides, instructional materials, brochures including non-downloadable electronic publications; providing educational electronic online databases for healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine and patient care

Trademark history

Date Document number Area Entry
August 22, 2022 2022/36 Gaz MX RAW: Refusal Transfer of Ownership
November 17, 2021 2021/48 Gaz CN RAW: Refusal Transfer of Ownership
July 27, 2020 2020/32 Gaz IL Rejection
April 17, 2020 2020/17 Gaz CN RAW: Rule 18ter(4) all goods and services protected
August 22, 2019 2019/38 Gaz NZ Rejection
July 30, 2019 2019/31 Gaz KR RAW: Rule 18ter(2)(ii) GP following a provisional refusal
February 28, 2019 2019/10 Gaz TR Rejection
February 12, 2019 2019/27 Gaz SM Rejection
January 24, 2019 2019/6 Gaz CO Rejection
January 11, 2019 2019/8 Gaz RS Rejection
January 10, 2019 2019/3 Gaz KR Rejection
December 27, 2018 2019/2 Gaz IL Rejection
September 7, 2018 2018/41 Gaz NZ Rejection
August 7, 2018 2018/39 Gaz TR RAW: Rule 18ter(2)(ii) GP following a provisional refusal
July 2, 2018 2018/42 Gaz IN RAW: Rule 18ter(2)(ii) GP following a provisional refusal
March 6, 2018 Correction
January 26, 2018 2018/5 Gaz KR Rejection
January 25, 2018 2018/4 Gaz MX Rejection
January 18, 2018 2018/4 Gaz TR Rejection
December 28, 2017 2018/4 Gaz JP RAW: Rule 18ter(2)(ii) GP following a provisional refusal
December 27, 2017 2018/3 Gaz CN Rejection
November 28, 2017 2017/50 Gaz TR Rejection
November 21, 2017 2017/48 Gaz RU RAW: Rule 18ter(2)(ii) GP following a provisional refusal
August 4, 2017 Correction
July 31, 2017 2017/31 Gaz CH Rejection
July 22, 2017 2017/42 Gaz VN Rejection
June 12, 2017 2017/27 Gaz IN Rejection
June 2, 2017 2017/22 Gaz NO RAW: Rule 18ter(2)(i) GP following a provisional refusal
May 19, 2017 2017/32 Gaz SG RAW: Rule 18ter(2)(ii) GP following a provisional refusal
May 19, 2017 2017/25 Gaz RU Rejection
March 23, 2017 2017/23 Gaz IS Rejection
March 9, 2017 2017/12 Gaz JP Rejection
February 22, 2017 2017/8 Gaz EM Rejection
February 13, 2017 2017/8 Gaz KR Rejection
December 20, 2016 GB RAW: Partial Ceasing Effect
December 15, 2016 2016/51 Gaz PH Rejection
December 11, 2016 2017/5 Gaz TR Rejection
December 1, 2016 2017/2 Gaz NO Rejection
November 10, 2016 2016/48 Gaz SG Rejection
October 20, 2016 2016/43 Gaz AU Rejection
March 31, 2016 GB Registration

ID: 141308581